Pharmaceutical

Covid-19: Anti-inflammatory drugs do not lead to a swifter hospital exit

Study shows patients taking abatacept, cenicriviroc, or Remicade in addition to SOC do not recover quicker compared to placebo.

Jul 11, 2023 - 20:00
Covid-19: Anti-inflammatory drugs do not lead to a swifter hospital exit
Study shows patients taking abatacept, cenicriviroc, or Remicade in addition to SOC do not recover quicker compared to placebo.
Read the original article

Tags:

Previous Article

Virpax plans three trials based on platform drug delivery systems in 2024

Next Article

Israeli company bags $4.2m contract to develop cell therapy for radiation poisoning

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Illumina chief commercial officer leaves to lead liquid biopsy startup Delfi

STAT+: Illumina chief commercial officer leaves to lead...

Jan 4, 2024

STAT+: FDA advisers vote against approving Intercept’s NASH drug

STAT+: FDA advisers vote against approving Intercept’s ...

May 19, 2023

UK to provide up to £39m for AMR research

UK to provide up to £39m for AMR research

May 22, 2023